Biotech

Particles, Patents, Pandemics, and Plaintiffs

What Lies Beneath

Incyte (INCY) – Q3 - 2025 Review

Another Pharma Patent Cliff Rebuild Story?

Pfizer ( PFE ) – Q3 2025 Review

The Stock That Fell To Earth

Q: Is There A Generational Opportunity In Biotech Stocks?

Biotech 2026 = Tech 2023?

Regeneron (REGN) – Q3 2025 Review

Eyeing A Breakout?

Novo Nordisk (NVO) - Q3 FY12/25 Earnings Review

Definitely Some Hair On This One

Initiating Coverage Of Merck & Co.

More evidence of rotation into healthcare stocks

ADMA Biologics Q2 FY12/25 Earnings Review

Running With The Big Dogs

BioNTech: More Than a One Hit Wonder?

Another 90% Club Member

mRNA Strikes Back: Moderna’s Attempt at a Sequel (MRNA Q3 FY12/2025 Earnings Review)

Our Biotech Coverage Expands.